Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Favorite
Like
Tweet
Print
Thomas C. Marbury, MD
President
Orlando Clinical Research Center
Poster(s):
A008: Using Clinical Data & Physiologically-based Pharmacokinetic Modelling to Assess the Effect of Hepatic Impairment on Avapritinib Pharmacokinetics to Guide Dose Adjustment
Monday, September 9, 2024
5:00 PM – 7:00 PM
ET
A008: Using Clinical Data & Physiologically-based Pharmacokinetic Modelling to Assess the Effect of Hepatic Impairment on Avapritinib Pharmacokinetics to Guide Dose Adjustment
Sunday, September 8, 2024
5:00 PM – 7:00 PM
ET
078: Pharmacokinetics, Pharmacodynamics & Safety of Rusfertide, A Hepcidin Mimetic, in Subjects With Hepatic Impairment & in Subjects With Renal Impairment
Sunday, September 8, 2024
5:00 PM – 7:00 PM
ET
